Anjana Pillai to Clinical Trials as Topic
This is a "connection" page, showing publications Anjana Pillai has written about Clinical Trials as Topic.
Connection Strength
0.033
-
Treatment-related toxicity and improved outcome from immunotherapy in hepatocellular cancer: Evidence from an FDA pooled analysis of landmark clinical trials with validation from routine practice. Eur J Cancer. 2021 11; 157:140-152.
Score: 0.033